BlackRock Investment Management, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$3,453,000
+18.1%
187,464
+21.7%
0.00%0.0%
Q3 2016$2,923,000
+31.1%
154,096
+11.4%
0.00%
+33.3%
Q2 2016$2,230,000
+56.4%
138,352
+16.4%
0.00%
+50.0%
Q1 2016$1,426,000
-15.3%
118,845
+0.5%
0.00%0.0%
Q4 2015$1,683,000
+21.7%
118,254
-0.0%
0.00%0.0%
Q3 2015$1,383,000
-33.3%
118,284
+0.2%
0.00%
-33.3%
Q2 2015$2,075,000
+408.6%
118,046
+332.8%
0.00%
+200.0%
Q1 2015$408,000
+36.5%
27,277
+5.8%
0.00%
Q4 2014$299,000
+1.7%
25,774
+2.2%
0.00%
Q3 2014$294,00025,2230.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders